Torsades de pointes and QT prolongation due to a combination of loratadine and amiodarone

Shaul Atar, Nahum A. Freedberg, Dante Antonelli, Tiberio Rosenfeld

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Torsades de pointes (TdP) has not been previously reported with loratadine. A 73-year old woman on chronic treatment with amiodarone for atrial fibrillation received loratadine and presented with syncope and multiple episodes of TdP. We suggest that QT interval should be monitored whenever loratadine is co-administered with drugs that may potentially prolong QT.

Original languageEnglish
Pages (from-to)785-786
Number of pages2
JournalPACE - Pacing and Clinical Electrophysiology
Volume26
Issue number3
DOIs
StatePublished - 1 Mar 2003
Externally publishedYes

Keywords

  • Amiodarone
  • Loratadine
  • QT dispersion
  • QT interval
  • Torsades de pointes

Fingerprint

Dive into the research topics of 'Torsades de pointes and QT prolongation due to a combination of loratadine and amiodarone'. Together they form a unique fingerprint.

Cite this